ISPOR - EE231 Calculating the Indirect Cost of Disease Recurrence and Subsequent Premature Mortality in Patients Diagnosed with Early-Stage Hepatocellular Carcinoma (HCC) in the United States (US)

EE231 Calculating the Indirect Cost of Disease Recurrence and Subsequent Premature Mortality in Patients Diagnosed with Early-Stage Hepatocellular Carcinoma (HCC) in the United States (US)

Abstract

Authors

V Ektare S Hegde SJ Snedecor D Muston

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 7S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now